128 related articles for article (PubMed ID: 33067910)
1. Developmental and reproductive safety evaluation of AV7909 anthrax vaccine candidate in rats.
Mylchreest E; Smiley MA; Ballin JD; Blauth B; Shearer J; Reece J; Ionin B; Savransky V
Birth Defects Res; 2021 Jan; 113(1):32-42. PubMed ID: 33067910
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the AV7909 Anthrax Vaccine Toxicity in Sprague Dawley Rats Following Three Intramuscular Administrations.
Rao VV; Godin CS; Lacy MJ; Inglefield JR; Park S; Blauth B; Reece JJ; Ionin B; Savransky V
Int J Toxicol; 2021 Oct; 40(5):442-452. PubMed ID: 34281421
[TBL] [Abstract][Full Text] [Related]
3. Repeat Dose Toxicity Study of the AV7909 Anthrax Vaccine Candidate in Juvenile Rats.
Zmarowski A; Ballin JD; Sharits J; Carrico K; Novak J; Shearer J; Blauth B; Ionin B; Reece J; Savransky V
Int J Toxicol; 2020 Jul; ():1091581820941412. PubMed ID: 32691648
[TBL] [Abstract][Full Text] [Related]
4. Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
Savransky V; Shearer JD; Gainey MR; Sanford DC; Sivko GS; Stark GV; Li N; Ionin B; Lacy MJ; Skiadopoulos MH
Vaccine; 2017 Sep; 35(37):4952-4959. PubMed ID: 28774566
[TBL] [Abstract][Full Text] [Related]
5. Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909.
Autumn Smiley M; Sanford DC; Triplett CA; Callahan D; Frolov V; Look J; Ruiz C; Reece JJ; Miles A; Ruiz E; Ionin B; Shearer JD; Savransky V
Vaccine; 2019 Oct; 37(43):6356-6361. PubMed ID: 31530467
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers.
Hopkins RJ; Daczkowski NF; Kaptur PE; Muse D; Sheldon E; LaForce C; Sari S; Rudge TL; Bernton E
Vaccine; 2013 Jun; 31(30):3051-8. PubMed ID: 23701746
[TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults.
Hopkins RJ; Kalsi G; Montalvo-Lugo VM; Sharma M; Wu Y; Muse DD; Sheldon EA; Hampel FC; Lemiale L
Vaccine; 2016 Apr; 34(18):2096-105. PubMed ID: 26979136
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of the AV7909 anthrax vaccine candidate in guinea pigs and nonhuman primates following two immunizations two weeks apart.
Shearer JD; Henning L; Sanford DC; Li N; Skiadopoulos MH; Reece JJ; Ionin B; Savransky V
Vaccine; 2021 Jan; 39(1):1-5. PubMed ID: 33199078
[TBL] [Abstract][Full Text] [Related]
9. Enhanced early innate and T cell-mediated responses in subjects immunized with Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909).
Minang JT; Inglefield JR; Harris AM; Lathey JL; Alleva DG; Sweeney DL; Hopkins RJ; Lacy MJ; Bernton EW
Vaccine; 2014 Nov; 32(50):6847-54. PubMed ID: 24530403
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or older.
Wolfe DN; Espeland EM; Gao Y; Lu D; Blatner G; Amass K; Horwith G; Tong XM; Hopkins R; David GL; Jepson BM; King JC
Vaccine; 2020 Nov; 38(50):7970-7976. PubMed ID: 33129609
[TBL] [Abstract][Full Text] [Related]
11. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax.
Henning L; Anderson M; Triplett C; Smith T; Boyce K; Hendey L; Ridenour A; Eng J; Schaeufele D; Wilson E; Sabourin CL; Adams LE; Babas T; Parish L; Wolfe D
Hum Vaccin Immunother; 2023 Dec; 19(3):2290345. PubMed ID: 38115181
[TBL] [Abstract][Full Text] [Related]
13. Lack of effects on fertility and developmental toxicity of a quadrivalent HPV vaccine in Sprague-Dawley rats.
Wise LD; Wolf JJ; Kaplanski CV; Pauley CJ; Ledwith BJ
Birth Defects Res B Dev Reprod Toxicol; 2008 Dec; 83(6):561-72. PubMed ID: 19025783
[TBL] [Abstract][Full Text] [Related]
14. Reproductive toxicity of exemestane, an antitumoral aromatase inactivator, in rats and rabbits.
Beltrame D; di Salle E; Giavini E; Gunnarsson K; Brughera M
Reprod Toxicol; 2001; 15(2):195-213. PubMed ID: 11297878
[TBL] [Abstract][Full Text] [Related]
15. Pre- and postnatal development studies of lasofoxifene, a selective estrogen receptor modulator (SERM), in Sprague-Dawley rats.
Weisenburger WP; Hagler AR; Tassinari MS
Birth Defects Res B Dev Reprod Toxicol; 2004 Jun; 71(3):171-84. PubMed ID: 15282738
[TBL] [Abstract][Full Text] [Related]
16. Development of a guinea pig inhalational anthrax model for evaluation of post-exposure prophylaxis efficacy of anthrax vaccines.
Perry MR; Ionin B; Barnewall RE; Vassar ML; Reece JJ; Park S; Lemiale L; Skiadopoulos MH; Shearer JD; Savransky V
Vaccine; 2020 Feb; 38(10):2307-2314. PubMed ID: 32029323
[TBL] [Abstract][Full Text] [Related]
17. Two-generation reproductive toxicity study of implanted depleted uranium (DU) in CD rats.
Arfsten DP; Still KR; Wilfong ER; Johnson EW; McInturf SM; Eggers JS; Schaeffer DJ; Bekkedal MY
J Toxicol Environ Health A; 2009; 72(6):410-27. PubMed ID: 19199148
[TBL] [Abstract][Full Text] [Related]
18. Lack of effects on female fertility or pre- and postnatal development of offspring in rats after exposure to AS03-adjuvanted recombinant plant-derived virus-like particle vaccine candidate for COVID-19.
Dubé C; Paris-Robidas S; Primakova I; Destexhe E; Ward BJ; Landry N; Trépanier S
Reprod Toxicol; 2022 Jan; 107():69-80. PubMed ID: 34838689
[TBL] [Abstract][Full Text] [Related]
19. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the reproductive and developmental toxicity of the AT1-selective angiotensin II receptor antagonist losartan in rats.
Spence SG; Cukierski MA; Manson JM; Robertson RT; Eydelloth RS
Teratology; 1995 Jun; 51(6):383-97. PubMed ID: 7502238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
